상세 보기
- 정재은;
- 강민구;
- 방준석
WEB OF SCIENCE
0SCOPUS
0초록
The purpose of this study was to investigate the effect of R&D investment and marketing expenses on theperformance of the Korean pharmaceutical companies. The top-ranked forty companies in Korea were selected and the 6-year-long data were analyzed to obtain the correlations among R&D intensity, marketing expenses, growth rate, operatingprofitability. In addition, the differences between innovative and non-innovative pharmaceutical companies were alsoexamined. Both the amount and the ratio of R&D investment over sales activities were significantly higher in theinnovative pharmaceutical companies compared with the non-innovative pharmaceutical companies. In these competitivecircumstances, R&D investment is indispensable for the sustainable growth in pharmaceutical companies. In conclusion,Korean pharmaceutical companies as well as government bodies should focus on more intensive and strategic R&Dactivities to increase the capabilities for developing innovative new products and future prosperity.
키워드
- 제목
- 국내 제약기업의 연구개발비 및 마케팅 비용이 기업성과에 미치는 영향 연구
- 제목 (타언어)
- The Effects of R&D Investment and Marketing Expenses on the Performance of Korean Pharmaceutical Companies
- 저자
- 정재은; 강민구; 방준석
- 발행일
- 2019-08
- 저널명
- 약 학 회 지
- 권
- 63
- 호
- 4
- 페이지
- 204 ~ 213